Skip to main content
. 2022 Mar 11;11(6):1549. doi: 10.3390/jcm11061549

Figure 2.

Figure 2

Kaplan–Meier event-free survival curves for freedom from MACE in two patient groups according to glycaemic variability (GV). Event-free survival rate was significantly lower in patients with high GV (log-rank test, p < 0.0001—solid blue line: GV ≤ 50 mg/dL; solid red line: GV > 50 mg/dL).